DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Spencer A, Lentzsch S, Weisel K, Avet-Loiseau H, Mark TM, Spicka I. et al.
Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: Updated analysis of CASTOR.
Haematologica 2018;
103: 2079-87
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.